Organogenesis Holdings (ORGO) Invested Capital (2017 - 2024)

Organogenesis Holdings' Invested Capital history runs 8 years deep, the most recent figure standing at $6.0 million for Q3 2024.

• On a quarterly basis, Invested Capital rose 120.81% year-over-year to $6.0 million in Q3 2024; TTM through Jun 2025 was $6.0 million, a 69.31% decrease from a year earlier, with the FY2023 full-year figure at $5.5 million, up 20.89% from the prior year.
• Invested Capital climbed to $6.0 million in Q3 2024 per ORGO's latest filing, from $5.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $11.7 million in Q3 2020 and bottomed at $101000.0 in Q1 2021.
• The 5-year median for Invested Capital is $4.5 million (2022), against an average of $4.4 million.
• Across the five-year window, Invested Capital tumbled 95.36% in 2021 and jumped 2995.05% in 2022, its largest moves.
• Year by year, Invested Capital stood at $4.3 million in 2020, then tumbled by 95.36% to $200000.0 in 2021, then soared by 2169.0% to $4.5 million in 2022, then gained by 20.89% to $5.5 million in 2023, then rose by 8.71% to $6.0 million in 2024.
• Per Business Quant, the three latest ORGO Invested Capital figures stand at $6.0 million (Q3 2024), $5.8 million (Q2 2024), and $5.5 million (Q1 2024).